Applied Micro Circuits Corporation (NASDAQ: AMCC) shares spiked 20.0 percent to close at $9.72 a share Tuesday. The stock traded in between $8.15 and $9.74 on volume of 2.91 million shares traded. FBR Capital has initiated coverage on the company with a “buy” rating and a price target of $11.00. Shares of Applied Micro Circuits have gained approximately 15.4 percent year-to-date.
Find out more about Applied Micro Circuits including full access to the free equity report at: www.RDInvesting.com/AMCC
Gevo, Inc. (NASDAQ: GEVO) shares surged 19.65 percent to close at $2.07 a share Tuesday. The stock traded in between $2.02 and $2.32 on volume of 9.56 million shares traded. The company announced that it has resumed commercial production of isobutanol at its Minn. plant. Shares of Gevo have gained approximately 34.4 percent year-to-date.
Find out more about Gevo including full access to the free equity report at: www.RDInvesting.com/GEVO
Premier Exhibitions, Inc. (NASDAQ: PRXI) shares increased 18.42 percent to close at $1.80 a share Tuesday. The stock traded in between $1.56 and $1.85 on volume of 657,580 shares traded. On Monday, the company announced a stock repurchase plan of up to 1.5 million shares. Shares of Premier Exhibitions have fallen approximately 33.5 percent year-to-date.
Find out more about Premier Exhibitions including full access to the free equity report at: www.RDInvesting.com/PRXI
Stemline Therapeutics Inc. (NASDAQ: STML) shares jumped 19.78 percent to close at $24.34 a share Tuesday. The stock traded in between $21.03 and $24.48 on volume of 514,704 shares traded. Ladenburg recently has initiated coverage on the company with a “buy” rating. Shares of Stemline Therapeutics Circuits have gained approximately 99.5 percent year-to-date.
Find out more about Stemline Therapeutics including full access to the free equity report at: www.RDInvesting.com/STML
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact: Research Driven Investing [email protected]